158
Participants
Start Date
July 13, 2021
Primary Completion Date
October 30, 2027
Study Completion Date
October 30, 2027
Apraglutide
Apraglutide is a synthetic peptide analogue of GLP-2 under development for treatment of SBS-IF, which acts as a full agonist at the GLP-2 receptor with in vitro potency and selectivity comparable with native GLP-2
Far Eastern Memorial Hospital, New Taipei City
Szent Imre University Teaching Hospital, Department of Gastroenterology, Budapest
Rigshospitalet - University Hospital Copenhagen, Department of Intestinal Failure and Liver Diseases, Copenhagen
UZ Leuven, Leuven
More og Romsdal Hospital Trust - Alesund Hospital, Ålesund
University of Szeged, Szeged
Mount Sinai Medical Center, New York
University Hospital Kralovske Vinohrady, Prague
Charite - University Hospital Berlin, Berlin
City of Health and Science of Turin, Turin
General University Hospital in Prague, Prague
Hospital of the University of Pennsylvania, Philadelphia
Asklepios Clinic St. Georg, Hamburg
Duke University Medical Center, Durham
University General Hospital Gregorio Maranon, Madrid
University Hospital 12 de Octubre, Madrid
University Hospital Plzen, Pilsen
Rambam Health Care Campus, Institute of Gastroenterology, Haifa
Hôpital Haut-Lévèque, Pessac
Gastroenterology Group of Naples, Naples
Vanderbilt University Medical Center, Nashville
Polyclinic S. Orsola-Malpighi, Bologna
University Hospital Virgen del Rocio (HUVR), Seville
Nantes University Hospital Center - Hotel Dieu Hospital, Nantes
Cleveland Clinic Foundation, Cleveland
University Hospital Muenster, Münster
Henry Ford Health System, Detroit
University Hospital Bonn, Bonn
Brabois Adults Hospital, Vandœuvre-lès-Nancy
Mayo Clinic - Rochester, Rochester
Northwestern University - Chicago, Chicago
University Hospital Brno, Brno
University of Nebraska Medical Center, Omaha
University Hospital Heidelberg, Heidelberg
South Lyon Hospital Center, Lyon
Ronald Reagan UCLA Medical Center, Los Angeles
Beaujon Hospital, Clichy
University of Washington Medical Center, Seattle
Chaim Sheba Medical Center, Tel Litwinsky
Cincinnati Children's Hospital Medical Center, Cincinnati
University Hospital Fundacion Favaloro, Buenos Aires
University Hospital Brussels, Brussels
University Hospital Hradec Kralove, Hradec Králové
Hospital Novy Jicin, Nový Jičín
Nice University Hospital Center - Archet 1 Hospital, Nice
Central Hospital of Northern Pest - Military Hospital, Budapest
Semmelweis University, Budapest
"University Polyclinic Foundation Agostino Gemelli - IRCCS", Rome
Yokohama City University Medical Center, Kanagawa
Yokohama Municipal Citizen's Hospital, Kanagawa
Osaka University Hospital, Osaka
Tohoku University Hospital, Sendai
JCHO Tokyo Yamate Medical Center, Tokyo
Stadmedica, Non-Public Healthcare Facility, Bydgoszcz
COPERNICUS Limited Liability Company, Nutrition Outpatient Clinic for Adults, Gdansk
M. Pirogow Provincial Specialized Hospital, Lodz
Gastromed Poland Sp. z o.o., Lublin
Stanley Dudrick Multispecialty Hospital, Skawina
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul
Sahlgrenska University Hospital, Sahlgrenska Intestinal Failure and Transplant Centre, Gothenburg
St Mark's Hospital, Harrow
Royal London Hospital, London
University College Hospital, London
Northern Care Alliance NHS Foundation Trust, Salford
VectivBio AG
INDUSTRY